Top Markets
Coin of the day
BioNexus Gene Lab Corp. BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp.

BGLC
株式のランク #35594
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala... BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
株価
$1.50
最終同期: 2026-09-21
時価総額
$3.63M
変化(1日)
-4.46%
変化(1年)
-72.68%
MY
取引 BioNexus Gene Lab Corp. (BGLC)

カテゴリー

BioNexus Gene Lab Corp.(BGLC)の営業利益率
September 2026 時点の営業利益率 TTM: -82.78%
BioNexus Gene Lab Corp. の最新の財務報告と株価によると、現在の営業利益率(TTM)は -82.78% です。2023 年末時点では -26.54% でした。
BioNexus Gene Lab Corp. の営業利益率の履歴(2016 から 2026)
各年末の営業利益率
営業利益率 変化
2026 (TTM) -82.78% 400.18%
2024 -16.55% -37.64%
2023 -26.54% 897.74%
2022 -2.66% -133.67%
2021 7.90% -29.34%
2020 11.18% -105.15%
2019 -217.17% -869.83%
2018 28.21% -123.75%
2017 -118.79% 0.00%
2016 0.00% 0.00%
同業他社の営業利益率
企業 営業利益率 営業利益率の差
14.57% -100.18%
US
20.29% -100.25%
US
0.00% -
US
5.38% -100.06%
US
0.00% -
US
企業の営業利益率とは?
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。